Related Experiment Video
Updated: Aug 11, 2026

15:09
The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease
Published on: October 3, 2012
Genetics of Parkinson's disease
1Klinikum Grosshadern, Ludwig-Maximilians-Universität, Munich, Germany.
Annals of Neurology
|September 28, 1998
Summary
Genetic factors contribute to Parkinson's disease (PD). While alpha-synuclein mutations are rare causes, new gene loci on chromosomes 4 and 2p13 are identified, aiding further PD gene discovery.
Area of Science:
- Neurogenetics
- Neurology
- Molecular Biology
Background:
- Familial aggregation and autosomal dominant inheritance patterns are established for Lewy body Parkinson's disease (PD).
- Previous research identified a gene locus for PD on chromosome 4, linked to alpha-synuclein.
- Sporadic and familial PD cases indicate that alpha-synuclein mutations are infrequent causes.
Purpose of the Study:
- To review the genetic basis of Lewy body Parkinson's disease.
- To discuss the identification of new genetic loci associated with PD.
- To explore strategies for discovering additional PD-related genes.
Main Methods:
- Review of case-control and twin studies demonstrating familial aggregation of PD.
- Genetic linkage analysis in large multigenerational families with autosomal dominant PD.
- Mutation screening in the alpha-synuclein gene and analysis of sporadic PD cases.
Main Results:
- A PD-associated locus was mapped to chromosome 4, with a mutation identified in the alpha-synuclein gene.
- Mutations in alpha-synuclein were found to be a rare cause of both familial and sporadic PD.
- A novel locus for autosomal dominantly inherited Lewy body PD was mapped to chromosome 2p13.
Conclusions:
- While alpha-synuclein is implicated, it is not a common cause of PD.
- Further research is needed to identify additional genes contributing to PD etiology.
- Mapping of new loci provides avenues for future genetic investigations into Parkinson's disease.
Related Concept Videos
Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

